← Back to Clinical Trials
Recruiting NCT06042387

Genome Analysis Across Populations in Inflammatory Bowel Disease

Trial Parameters

Condition Ulcerative Colitis
Sponsor Mount Sinai Hospital, Canada
Study Type OBSERVATIONAL
Phase N/A
Enrollment 150
Sex ALL
Min Age N/A
Max Age N/A
Start Date 2022-05-01
Completion 2027-05
Interventions
Blood or saliva sample collection

Brief Summary

Objective: To use clinical, genetic and genome analysis to better understand and define the genetic and environmental factors that contribute to IBD within affected populations.

Eligibility Criteria

Inclusion Criteria: * Subjects: diagnosed with Inflammatory Bowel Disease (Crohn's disease, ulcerative colitis, IBD-undetermined) * Available medical records to confirm IBD diagnosis (Crohn's disease, Ulcerative colitis, IBD undetermined (IBD-U)) * Healthy controls: no personal history of IBD, no family history of IBD, no history of unexplained chronic diarrhea/blood in stool/anemia/abdominal pain/weight loss * Any age Exclusion Criteria: \- Subjects with other gastrointestinal conditions not meeting the above IBD or Healthy Control criteria

Related Trials